ACE and dementia: These results are similar to those were previously explained by Abbassi et al. [83], Ali et al. [84], and Mohapatra et al. [79], who confirmed that CAP as a ACE inhibitor significantly improves cognitive function in LPS-induced dementia in rats by potentiating the antioxidant status of brain defense system by increasing the CAT and SOD content and decreased MDA production.